Stephen Couban

Summary

Affiliation: Nova Scotia
Country: Canada

Publications

  1. ncbi request reprint The source of cells for allografting
    Stephen Couban
    Department of Medicine, Queen Elizaberth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Biol Blood Marrow Transplant 9:669-73. 2003
  2. ncbi request reprint Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer
    Stephen Couban
    Department of Medicine, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Room 417, Bethune Bldg, 1278 Tower Rd, Halifax, Nova Scotia B3H 2Y9, Canada
    J Clin Oncol 23:4063-9. 2005
  3. ncbi request reprint Catheter-associated thrombosis in patients with malignancy
    Sudeep P Shivakumar
    Department of Medicine, Dalhousie University and Capital District Health Authority, Halifax, Nova Scotia, Canada
    J Clin Oncol 27:4858-64. 2009
  4. doi request reprint A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186
    David A Macdonald
    Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
    Leuk Lymphoma 54:760-6. 2013
  5. ncbi request reprint A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation
    Kathryn E Webert
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Transfusion 48:81-91. 2008
  6. ncbi request reprint Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit
    Andrea K Kew
    Department of Medicine, Dalhousie University, and Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
    Biol Blood Marrow Transplant 12:301-5. 2006
  7. doi request reprint Stiff-person syndrome associated with multiple myeloma following autologous bone marrow transplantation
    Erin C Clow
    Department of Medicine, Dalhousie University, Halifax, Nova Scotia B3H 3A7, Canada
    Muscle Nerve 38:1649-52. 2008
  8. ncbi request reprint Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation
    Somaya El-Seisi
    Department of Medicine, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
    Biol Blood Marrow Transplant 9:683-8. 2003
  9. ncbi request reprint A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies
    Stephen Couban
    Department of Medicine, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
    Blood 100:1525-31. 2002
  10. ncbi request reprint Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors
    Luke R Shier
    Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
    Biol Blood Marrow Transplant 10:624-34. 2004

Collaborators

Detail Information

Publications18

  1. ncbi request reprint The source of cells for allografting
    Stephen Couban
    Department of Medicine, Queen Elizaberth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Biol Blood Marrow Transplant 9:669-73. 2003
    ..It is not clear, however, whether these benefits also extend to children or those undergoing matched unrelated transplantation...
  2. ncbi request reprint Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer
    Stephen Couban
    Department of Medicine, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Room 417, Bethune Bldg, 1278 Tower Rd, Halifax, Nova Scotia B3H 2Y9, Canada
    J Clin Oncol 23:4063-9. 2005
    ..In this multicenter, randomized, placebo-controlled clinical trial, we studied whether warfarin 1 mg daily reduces the incidence of symptomatic central venous catheter (CVC) -associated thrombosis in patients with cancer...
  3. ncbi request reprint Catheter-associated thrombosis in patients with malignancy
    Sudeep P Shivakumar
    Department of Medicine, Dalhousie University and Capital District Health Authority, Halifax, Nova Scotia, Canada
    J Clin Oncol 27:4858-64. 2009
    ..The care of pediatric patients with malignancy and catheter-associated thrombosis will also be addressed...
  4. doi request reprint A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186
    David A Macdonald
    Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
    Leuk Lymphoma 54:760-6. 2013
    ..We conclude that this combination of sorafenib and cytarabine has limited activity in this unselected cohort of elderly patients with AML/MDS in which FLT3 mutations seemed underrepresented...
  5. ncbi request reprint A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation
    Kathryn E Webert
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Transfusion 48:81-91. 2008
    ..Anemia may be an important factor contributing to an increased risk of bleeding, particularly in patients with thrombocytopenia...
  6. ncbi request reprint Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit
    Andrea K Kew
    Department of Medicine, Dalhousie University, and Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
    Biol Blood Marrow Transplant 12:301-5. 2006
    ..However, SCT recipients requiring vasopressor support had very poor outcomes. These findings will be important in deciding which SCT patients may benefit from ICU admission and care...
  7. doi request reprint Stiff-person syndrome associated with multiple myeloma following autologous bone marrow transplantation
    Erin C Clow
    Department of Medicine, Dalhousie University, Halifax, Nova Scotia B3H 3A7, Canada
    Muscle Nerve 38:1649-52. 2008
    ..We speculate that an aberrant posttransplant immune response may have caused both the SPS and an autologous graft-versus-myeloma effect, resulting in prolonged remission posttransplant...
  8. ncbi request reprint Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation
    Somaya El-Seisi
    Department of Medicine, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada
    Biol Blood Marrow Transplant 9:683-8. 2003
    ..Although we did not demonstrate associations of these histologic changes with clinical variables before death, larger studies with prospectively collected renal tissue are warranted...
  9. ncbi request reprint A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies
    Stephen Couban
    Department of Medicine, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
    Blood 100:1525-31. 2002
    ....
  10. ncbi request reprint Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors
    Luke R Shier
    Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
    Biol Blood Marrow Transplant 10:624-34. 2004
    ..Accompanying effects on immune cell populations are consistent with a greater ability of G-BM to promote tolerance in allogeneic recipients, and this could contribute to a lower rate of chronic graft-versus-host disease...
  11. doi request reprint Laparoscopic accessory splenectomy: the value of perioperative localization studies
    Abdulmalik M S Altaf
    Queen Elizabeth II Health Sciences Center, Dalhousie University, Room 8 028 Victoria Building, 1278 Tower Road, Halifax, NS, B3H 2Y9, Canada
    Surg Endosc 23:2675-9. 2009
    ..Laparoscopic intraoperative identification of an accessory spleen can be difficult. The authors report their experience with laparoscopic accessory splenectomy (LAS) and the use of perioperative localization methods for this procedure...
  12. doi request reprint Lenalidomide plus melphalan without prednisone for previously untreated older patients with multiple myeloma: a phase II trial
    Darrell J White
    Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Clin Lymphoma Myeloma Leuk 13:19-24. 2013
    ..We conducted a phase II trial that evaluated the tolerability and efficacy of combining lenalidomide with melphalan in previously untreated patients with multiple myeloma who were not candidates for autologous stem cell transplantation...
  13. doi request reprint The experience of caring for a spouse undergoing hematopoietic stem cell transplantation: opening Pandora's box
    Brenda Sabo
    School of Nursing, Dalhousie University, Halifax, Nova Scotia, Canada
    Cancer Nurs 36:29-40. 2013
    ....
  14. ncbi request reprint Acute promyelocytic leukemia: a novel PML/RARalpha fusion that generates a frameshift in the RARalpha transcript and ATRA resistance
    Adham Zayed
    Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, NS, Canada
    Leuk Lymphoma 48:489-96. 2007
    ..Since none of the RARalpha functional domains are maintained, this case highlights the possibility that PML/RARalpha may directly affect promyelocyte differentiation through disruption of PML function...
  15. ncbi request reprint Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction
    Stephen Couban
    Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
    Transfusion 42:753-8. 2002
    ..The effectiveness of plasma reduction after storage and WBC reduction of platelet concentrates before storage was studied in pediatric recipients of platelet transfusions...
  16. ncbi request reprint Intracranial presentation of systemic Hodgkin's disease
    Khalid Hirmiz
    Department of Radiation Oncology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada
    Leuk Lymphoma 45:1667-71. 2004
    ..Treatment has varied extensively but includes whole brain radiation with or without combination chemotherapy. Our literature review suggests that the prognosis is not dismal with appropriate treatment...
  17. ncbi request reprint An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting
    Christopher Bredeson
    Medical College of Wisconsin, Milwaukee 53226, USA
    Biol Blood Marrow Transplant 10:405-14. 2004
    ..Further work is needed to decrease donor anxiety and symptoms. If both BM and PBPC donation are feasible, then the graft source should be dictated by the predicted patient outcome as determined from the results of randomized trials...
  18. ncbi request reprint Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16
    Michael Crump
    National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada
    J Clin Oncol 26:37-43. 2008
    ....